Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial
Rachel S Midgley, Christopher C McConkey, Elaine C Johnstone, et al.
The Lancet. Oncology
|
September 24, 2016
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Rachel S Kerr, Sharon Love, Eva Segelov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2011
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer
Richard G Gray, Philip Quirke, Kelly Handley, et al.
Science Translational Medicine
|
July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapy
Mark R Middleton, Richard Knox, Emma Cattell, et al.
The EMBO Journal
|
February 14, 2012
Arginine methylation controls growth regulation by E2F-1
Er-Chieh Cho, Shunsheng Zheng, Shonagh Munro, et al.
The Lancet. Oncology
|
August 14, 2022
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
Andreas Kleppe, Ole-Johan Skrede, Sepp De Raedt, et al.
The New England Journal of Medicine
|
March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
John P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
The Lancet. Oncology
|
February 7, 2018
Chromatin organisation and cancer prognosis: a pan-cancer study
Andreas Kleppe, Fritz Albregtsen, Ljiljana Vlatkovic, et al.
Cell
|
December 17, 2025
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma
Zhaomin Deng, Lu Pu, Kai Deng, et al.
Clinical and Experimental Pharmacology & Physiology
|
November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapy
Peter F Searle, Ming-Jen Chen, Longqin Hu, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial
Rachel S Midgley, Christopher C McConkey, Elaine C Johnstone, et al.
The Lancet. Oncology
|
September 24, 2016
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Rachel S Kerr, Sharon Love, Eva Segelov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2011
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer
Richard G Gray, Philip Quirke, Kelly Handley, et al.
Science Translational Medicine
|
July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapy
Mark R Middleton, Richard Knox, Emma Cattell, et al.
The EMBO Journal
|
February 14, 2012
Arginine methylation controls growth regulation by E2F-1
Er-Chieh Cho, Shunsheng Zheng, Shonagh Munro, et al.
The Lancet. Oncology
|
August 14, 2022
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
Andreas Kleppe, Ole-Johan Skrede, Sepp De Raedt, et al.
The New England Journal of Medicine
|
March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
John P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
The Lancet. Oncology
|
February 7, 2018
Chromatin organisation and cancer prognosis: a pan-cancer study
Andreas Kleppe, Fritz Albregtsen, Ljiljana Vlatkovic, et al.
Cell
|
December 17, 2025
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma
Zhaomin Deng, Lu Pu, Kai Deng, et al.
Clinical and Experimental Pharmacology & Physiology
|
November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapy
Peter F Searle, Ming-Jen Chen, Longqin Hu, et al.
Page
of 12